Dear Editor,The Left Atrial Volume Index (LAVi) is a measurement that has gained importance in daily
clinical practice due to evidence of its capacity to predict mortality, in patients
followed after an Acute Myocardial Infarction (AMI), as well as in the general
population[1].The study by Secundo Junior et al. sought to evaluate the role of LAVi as a predictor of
late events in patients with acute coronary syndrome[2]. This study was able to corroborate previous findings in patients
with AMI and demonstrated that increased LAVi may also be able to predict major
cardiovascular events in patients with unstable angina. Correspondingly, it showed that
patients with increased LAVi were those with higher prevalence of systemic arterial
hypertension (SAH), previous AMI and angioplasty, of older age, with higher body mass index
(BMI), lower left ventricular (LV) ejection fraction and more severe diastolic dysfunction,
showing that the index may be a marker related to a higher occurrence of cardiovascular
diseases and comorbidities.In cohort studies, a significant problem is the presence of non-controlled variables, which
are potential confounding factors that can possibly interfere with the results. The degree
of reperfusion success (assessed by TIMI flow, myocardial blush or ST-segment recovery),
which maintains significant correlation with better survival, can be one of those factors
not measured in this study[3]. Another
confounding factor could be the incidence of atrial fibrillation (AF) in the extra-hospital
period. The causal association between AF and ischemic cerebrovascular accident (CVA) has
been documented, regardless of echocardiographic findings. It is associated with a four to
five-fold increase in the risk of ischemic CVA[4] and it is responsible for more than 15% of these events in individuals
in all age ranges and 30% in individuals older than 80 years[5].Thus, it is not clear, in the results of Secundo Junior et al., whether the high incidence
of CVA in the non-hospital follow-up was due only to the increase in LAVi or the possible
occurrence of this arrhythmia, and one cannot say that there was no influence of better or
worse reperfusion on the incidence of events in either group.Thank you for your comments and interest in our research and the SOLAR registry.
Regarding the potential influence of atrial fibrillation on the higher incidence of
ischemic cerebrovascular accident (CVA) in patients with high Left Atrial Volume Index
(LAVi), we believe it has not occurred in a significant manner in our study. As shown in
Table 3, no significant difference was found regarding atrial fibrillation as a late
event between the groups (p = 0.14). As for the possible inclusion of the degree of
reperfusion success, we consider it unlikely the presence of any influence of this
factor, as the aforementioned table showed no difference regarding hospital treatment
between the high LAVi and low LAVi groups, for both clinical treatment alone (p = 0.42)
and for angioplasty (p = 0.56), as well as for myocardial revascularization
(p = 0.68).Additionally, we believe that the chosen model was the most adequate to the study design
and statistical analysis. This was demonstrated by the number of factors (eight)
considering the sample size, avoiding overfitting and remaining within a prudent
association between predictors and achieved number of events. Several post
hoc tests were used, such as landmark analysis, proportional hazards
assumption test and obtaining Schoenfeld residuals.These tests showed absence of violations, robust estimates and satisfactory fit of the
final model which, incidentally, included factors of extreme clinical relevance and that
are easy to acquire, such as the age, gender, presence of diabetes or hypertension acute
coronary syndrome type and ejection fraction, then adjusted to LAVi. Finally, because
this is a registry, it is indeed necessary to consider the virtual presence of
confounding factors and interactions, which was duly explained in the midst of the
article, when we describe the potential limitations of this study.Sincerely,Marcos Antônio Almeida SantosAntônio Carlos Sobral SousaJosé Alves Secundo Júnior
Authors: Jacob E Moller; Graham S Hillis; Jae K Oh; James B Seward; Guy S Reeder; R Scott Wright; Seung W Park; Kent R Bailey; Patricia A Pellikka Journal: Circulation Date: 2003-04-14 Impact factor: 29.690
Authors: Jose Alves Secundo Junior; Marcos Antonio Almeida Santos; Gustavo Baptista de Almeida Faro; Camile Bittencourt Soares; Allyson Matos Porto Silva; Paulo Fernando Carvalho Secundo; Clarissa Karine Cardoso Teixeira; Joselina Luzia Menezes Oliveira; Jose Augusto Soares Barreto Filho; Antônio Carlos Sobral Sousa Journal: Arq Bras Cardiol Date: 2014-08-13 Impact factor: 2.000